Thomas P. Sanderson

901 total citations
33 papers, 636 citations indexed

About

Thomas P. Sanderson is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Thomas P. Sanderson has authored 33 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Oncology. Recurrent topics in Thomas P. Sanderson's work include Peroxisome Proliferator-Activated Receptors (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Reproductive tract infections research (3 papers). Thomas P. Sanderson is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Reproductive tract infections research (3 papers). Thomas P. Sanderson collaborates with scholars based in United States, Germany and Canada. Thomas P. Sanderson's co-authors include J.J. Veenhuizen, J.K. Drackley, J.W. Young, L. D. Miller, M. Richard, Mark A. Dominick, Sarah H. Tannehill‐Gregg, Howard T. Hill, Jeffrey J. Zimmerman and M. L. Frey and has published in prestigious journals such as Gut, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Thomas P. Sanderson

32 papers receiving 590 citations

Peers

Thomas P. Sanderson

ACS

GENET

ASZ

Cheng Xia China

Kerry Barker United States

Isabelle Parmentier Belgium

Zhenhua Tang China

Jiusheng Wu China

Emily McGovern Australia

Xun Tan China

Xiaoge Sun China

Shin-ichi ITAGAKI Japan

Jinghua Cheng China

Cheng Xia China

Thomas P. Sanderson

427 ×2.1

ACS

261 ×1.4

GENET

145 ×0.9

ASZ

213 ×1.3

31 ×0.2

Citations per year, relative to Thomas P. Sanderson Thomas P. Sanderson (= 1×) peers Cheng Xia

Countries citing papers authored by Thomas P. Sanderson

Since Specialization

Citations

This map shows the geographic impact of Thomas P. Sanderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Sanderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Sanderson more than expected).

Fields of papers citing papers by Thomas P. Sanderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas P. Sanderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Sanderson. The network helps show where Thomas P. Sanderson may publish in the future.

Co-authorship network of co-authors of Thomas P. Sanderson

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P. Sanderson. A scholar is included among the top collaborators of Thomas P. Sanderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P. Sanderson. Thomas P. Sanderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sanderson, Thomas P. & Theophilus Samuels. (2025). A cohort study evaluating myocardial work and right ventricle strain in sepsis in critical care. Scientific Reports. 15(1). 16606–16606. 2 indexed citations

Sivaraman, Lakshmi & Thomas P. Sanderson. (2023). Gamma secretase inhibition: Effects on fertility and embryo-fetal development in rats. Toxicology and Applied Pharmacology. 469. 116512–116512.

Sanderson, Thomas P., et al.. (2018). Nonclinical Safety Assessment of the γ-Secretase Inhibitor Avagacestat. Toxicological Sciences. 163(2). 525–542. 10 indexed citations

Guha, Mausumee, James K. Hennan, Damir Simic, et al.. (2017). In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension. Cancer Chemotherapy and Pharmacology. 79(4). 711–723. 12 indexed citations

Li, Wenying, Kevin J. Trouba, Li Ma, et al.. (2017). In Vitro Metabolite Formation in Human Hepatocytes and Cardiomyocytes and Metabolism and Tissue Distribution in Monkeys of the 2′-C-Methylguanosine Prodrug BMS-986094. International Journal of Toxicology. 36(1). 35–49. 6 indexed citations

Gill, Michael, James K. Hennan, Denise I. Bounous, et al.. (2016). From the Cover: Investigative Nonclinical Cardiovascular Safety and Toxicology Studies with BMS-986094, an NS5b RNA-Dependent RNA Polymerase Inhibitor. Toxicological Sciences. 155(2). 348–362. 7 indexed citations

Wang, Faye, Jae Kwagh, Megan K. Fuller, et al.. (2016). Effects of BMS-986094, a Guanosine Nucleotide Analogue, on Mitochondrial DNA Synthesis and Function. Toxicological Sciences. 153(2). 396–408. 10 indexed citations

Bunch, Roderick T., et al.. (2015). MicroRNA as biomarkers of mitochondrial toxicity. Toxicology and Applied Pharmacology. 312. 26–33. 10 indexed citations

Guha, Mausumee, et al.. (2014). Nonclinical Safety Profile of BMS-986001, a Nucleoside Transcriptase Inhibitor for Combination Retroviral Therapy. International Journal of Toxicology. 33(3). 204–218. 2 indexed citations

10.

Vleet, Terry R. Van, Damir Simic, Theodora W. Salcedo, et al.. (2014). d‐α‐tocopheryl polyethylene glycol 1000 succinate‐containing vehicles provide no detectable chemoprotection from oxidative damage. Journal of Applied Toxicology. 35(7). 791–798. 1 indexed citations

11.

Simic, Damir, Emily R. Haines, Aiqing He, et al.. (2013). MicroRNA changes associated with atypical CYP1A1 inducer BMS-764459. Toxicology. 311(3). 169–177. 3 indexed citations

12.

Simic, Damir, et al.. (2013). Determination of Relative Notch1 and γ-Secretase-Related Gene Expression in Puromycin-Treated Microdissected Rat Kidneys. Gene Expression. 16(1). 39–47. 2 indexed citations

13.

Tannehill‐Gregg, Sarah H., Thomas P. Sanderson, Daniel J. Minnema, et al.. (2007). Rodent Carcinogenicity Profile of the Antidiabetic Dual PPAR α and γ Agonist Muraglitazar. Toxicological Sciences. 98(1). 258–270. 39 indexed citations

14.

Dominick, Mark A., et al.. (2007). Nonclinical Safety Evaluation of Muraglitazar, a Novel PPARα/γ Agonist. Toxicological Sciences. 100(1). 248–258. 27 indexed citations

15.

Vleet, Terry R. Van, Thomas P. Sanderson, Samuel M. Cohen, et al.. (2006). Subchronic Urinary Bladder Effects of Muraglitazar in Male Rats1. Toxicological Sciences. 96(1). 58–71. 15 indexed citations

16.

Wesley, Irene V., Thomas P. Sanderson, David J. Larson, et al.. (1997). Application of multiplex polymerase chain reaction for rapid identification of Campylobacter jejuni and C coli associated with reproductive failure. American Journal of Veterinary Research. 58(10). 1070–1075. 5 indexed citations

17.

Fretland, D. J., Thomas P. Sanderson, Philip L. Smith, et al.. (1995). Oral efficacy of a leukotriene B4 receptor antagonist in colitic cotton-top tamarins.. Gut. 37(5). 702–707. 7 indexed citations

18.

Swenson, Sabrina L., Howard T. Hill, Jeffrey J. Zimmerman, et al.. (1994). Excretion of porcine reproductive and respiratory syndrome virus in semen after experimentally induced infection in boars. Journal of the American Veterinary Medical Association. 204(12). 1943–1948. 109 indexed citations

19.

Halbur, Patrick G., P. S. Paul, John J. Andrews, et al.. (1993). Experimental transmission of an apparent viral pneumonia in conventional and gnotobiotic pigs. Veterinary Record. 132(11). 263–266. 16 indexed citations

20.

Veenhuizen, J.J., J.K. Drackley, M. Richard, et al.. (1991). Metabolic Changes in Blood and Liver During Development and Early Treatment of Experimental Fatty Liver and Ketosis in Cows. Journal of Dairy Science. 74(12). 4238–4253. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact